DETERMINATION OF SIMULTANEOUS IRBESARTAN AND HYDROCHLOROTHIAZIDE BY ULTRAVIOLET SPECTROPHOTOMETRY WITH DUAL WAVELENGTH METHOD

Authors

  • Hafid Syahputra Faculty of Pharmacy, University of Sumatera Utara
  • M. Si. Apt Muchlisyam Professor, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Sumatera Utara, Medan, Indonesia
  • M.S. Apt Masfria Professor, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Sumatera Utara, Medan, Indonesia

DOI:

https://doi.org/10.22270/ajprd.v7i3.512

Keywords:

Irbesartan, hydrochlorothiazide, ultraviolet spectrophotometry, dual wavelength method

Abstract

Objective: The present study was aimed to develop a spectrophotometric method by dual wavelength method in simultaneous analysis of irbesartan and hydrochlorothiazide on tablet preparations without separation. Irbesartan and hydrochlorothiazide are a group of anti-hypertensive drugs that are very effective and safe to use to reduce blood pressure and edema. These drugs often given in combination with these active ingredients can cause problems in quantitative analysis for the quality control of preparations.

Methods: The study was carried out experimentally with a spectrophotometric method, one of which was dual wavelength method and then tested its validity based on validation parameters, namely linearity, accuracy, precision, LOD and LOQ and intraday and interday. Then, this method of irbesartan and hydrochlorothiazide in tablet preparations.

Results: The results of the study were showed that the application of dual wavelength method on the concentration was carried out at λ 263.4 nm and 281 nm for irbesartan and at λ 243.4 nm and 247.6 nm for hydrochlorothiazide. The results obtained by irbesartan and hydrochlorothiazide on tablets were (108.04 ± 2.696) and (94.28 ± 4.48)% respectively, and with good precision and accuracy.

Conclusions: The ultraviolet spectrophotometry method is dual wavelength method successfully applied for the determination of the concentration of irbesartan and hydrochlorothiazide in tablets.

Downloads

Download data is not yet available.

Author Biographies

Hafid Syahputra, Faculty of Pharmacy, University of Sumatera Utara

Faculty of Pharmacy, University of Sumatera Utara,Indonesia

M. Si. Apt Muchlisyam, Professor, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Sumatera Utara, Medan, Indonesia

Professor, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Sumatera Utara, Medan, Indonesia

M.S. Apt Masfria, Professor, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Sumatera Utara, Medan, Indonesia

Professor, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Sumatera Utara, Medan, Indonesia

References

1. Moffat AC, Osselton MD, Widdop B. Clarke’s Analysis of Drugs and Poisons. 4th ed. London: Pharmaceutical Press; 2011. 73–85 p.
2. Raskin P, Guthrie R, Flack JM, Reeves RA, Saini R. The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide. J Hum Hypertension. 1999;(13):683–7.
3. Vahora S, Mehta F, Chhalotiya U, Shah D. Dual Wavelength Spectrophotometric Method for Estimation of Cilnidipine and Telmisartan in Their Combined Dosage Form. Res Rev J Pharm Anal. 2014;3(2):22–9.
4. Bindaiya S, Bankey S, D.jain. Simultaneous Determination of nitazoxanide and ofloxacine in Tablet Dosage Form by Ultraviolet Spectrophotometry (Dual Wavelength Method). intJChemTechRes. 2010;1(2):11–5.
5. Pradhan PK, Rajput PN, Kumar N, Joshi B, Upadhyay UM. Simultaneous estimation of Flurbiprofen and Gatifloxacin by dual wavelength UV spectroscopy method in an eye drops. Int J Pharm Sci Rev Res. 2014;27(2):96–9.
6. Kamal AH, El-malla SF, Hammad SF. A Review on Uv Spectrophotometric Methods for Simultaneous Multicomponent Analysis. Eur J Pharm Med Res. 2016;3(2):348–60.
7. Harmita. Petunjuk Pelaksanaan Validasi Metode dan Cara Perhitungannya. Maj Ilmu Kefarmasian. 2004;I(3):117–35.
8. Ermer J, John JH. Method Validation in Pharmaceutical Analysis: A Guide to Best Practice [Internet]. Weinheim, FRG: Wiley-VCH Verlag GmbH & Co. KGaA; 2005. 1–403 p. Available from: http://doi.wiley.com/10.1002/3527604685

Published

2019-06-15

How to Cite

Syahputra, H., Muchlisyam, M. S. A., & Masfria, M. A. (2019). DETERMINATION OF SIMULTANEOUS IRBESARTAN AND HYDROCHLOROTHIAZIDE BY ULTRAVIOLET SPECTROPHOTOMETRY WITH DUAL WAVELENGTH METHOD. Asian Journal of Pharmaceutical Research and Development, 7(3), 1–4. https://doi.org/10.22270/ajprd.v7i3.512

Issue

Vol. 7 No. 3 (2019): Vol 7 No 3 (2019): Volume 7 Issue 3 May - June 2019

Section

Research Articles

AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).